Literature DB >> 26501167

Photosensitizers and Photodynamic Therapy: Verteporfin.

Maurizio Battaglia Parodi, Carlo La Spina, Luigi Berchicci, Giuseppe Petruzzi, Francesco Bandello.   

Abstract

Photodynamic therapy (PDT) is a phototherapy in which a photosensitive dye is injected into a peripheral vein and activated by light in order to occlude choroidal vessels or change their permeability. PDT has been largely applied in the treatment of choroidal neovascularization (CNV), especially CNV related to age-related macular degeneration, but was also of benefit in other diseases, including central serous chorioretinopathy and choroidal hemangioma.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26501167     DOI: 10.1159/000434704

Source DB:  PubMed          Journal:  Dev Ophthalmol        ISSN: 0250-3751


  8 in total

1.  Verteporfin induces apoptosis and eliminates cancer stem-like cells in uveal melanoma in the absence of light activation.

Authors:  Ya-Wen Ma; Yi-Zhi Liu; Jing-Xuan Pan
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

2.  Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma.

Authors:  Corinne Bouvier; Nicolas Macagno; Quy Nguyen; Anderson Loundou; Carine Jiguet-Jiglaire; Jean-Claude Gentet; Jean-Luc Jouve; Alexandre Rochwerger; Jean-Camille Mattei; Daniel Bouvard; Sébastien Salas
Journal:  Oncotarget       Date:  2016-10-04

3.  X-ray induced photodynamic therapy (PDT) with a mitochondria-targeted liposome delivery system.

Authors:  Xuefan Gu; Chao Shen; Hua Li; Ewa M Goldys; Wei Deng
Journal:  J Nanobiotechnology       Date:  2020-06-10       Impact factor: 10.435

4.  Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer.

Authors:  Mi Ran Yun; Hun Mi Choi; You Won Lee; Hyeong Seok Joo; Chae Won Park; Jae Woo Choi; Dong Hwi Kim; Han Na Kang; Kyoung-Ho Pyo; Eun Joo Shin; Hyo Sup Shim; Ross A Soo; James Chih-Hsin Yang; Sung Sook Lee; Hyun Chang; Min Hwan Kim; Min Hee Hong; Hye Ryun Kim; Byoung Chul Cho
Journal:  EMBO Mol Med       Date:  2019-10-21       Impact factor: 12.137

5.  Verteporfin Promotes the Apoptosis and Inhibits the Proliferation, Migration, and Invasion of Cervical Cancer Cells by Downregulating SULT2B1 Expression.

Authors:  Lijun Yin; Guilin Chen
Journal:  Med Sci Monit       Date:  2020-10-20

6.  Verteporfin-mediated on/off photoswitching functions synergistically to treat choroidal vascular diseases.

Authors:  Yahan Ju; Xiaochan Dai; Zhimin Tang; Zunzhen Ming; Ni Ni; Dongqing Zhu; Jing Zhang; Bo Ma; Jiajing Wang; Rui Huang; Siyu Zhao; Yan Pang; Ping Gu
Journal:  Bioact Mater       Date:  2022-02-01

7.  Verteporfin-Loaded Lipid Nanoparticles Improve Ovarian Cancer Photodynamic Therapy In Vitro and In Vivo.

Authors:  Thierry Michy; Thibault Massias; Claire Bernard; Laetitia Vanwonterghem; Maxime Henry; Mélanie Guidetti; Guy Royal; Jean-Luc Coll; Isabelle Texier; Véronique Josserand; And Amandine Hurbin
Journal:  Cancers (Basel)       Date:  2019-11-08       Impact factor: 6.639

8.  Verteporfin inhibits cell proliferation and induces apoptosis in different subtypes of breast cancer cell lines without light activation.

Authors:  Changran Wei; Xiangqi Li
Journal:  BMC Cancer       Date:  2020-10-29       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.